---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-068511"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:43:06.784370+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology says SVB exposure immaterial; loan facility with SVB under review

## Summary
- Uninsured cash at SVB is less than 0.8% of total cash equivalents and investments.
- Majority of cash in segregated custody at U.S. Bank via SAM; SVB has no claim.
- Has up to $100M secured term loan; SVB funded 50%; assessing options for SVB's position.

## SEC filing metadata
- accession: 0001193125-23-068511
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000119312523068511/0001193125-23-068511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000119312523068511/d456798d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-068511
- JSON: https://secwatch.observer/filing/0001193125-23-068511.json
- Plain text: https://secwatch.observer/filing/0001193125-23-068511.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.